- Home
- Publications
- Publication Search
- Publication Details
Title
The aurora kinases in cell cycle and leukemia
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 5, Pages 537-545
Publisher
Springer Nature
Online
2014-03-17
DOI
10.1038/onc.2014.14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
- (2013) S. I. Nikolaev et al. BLOOD
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
- (2013) Seiichi Okabe et al. Cancer Cell International
- Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in acute myeloid leukemia cells
- (2013) Takahiro Yamauchi et al. CANCER SCIENCE
- A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
- (2013) E. Raymond et al. INVESTIGATIONAL NEW DRUGS
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
- (2013) J D E de Rooij et al. LEUKEMIA
- A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
- (2013) Carlos Graux et al. LEUKEMIA RESEARCH
- Gene Amplification and Overexpression of Aurora-C in Breast and Prostate Cancer Cell Lines
- (2013) Ali Zekri et al. ONCOLOGY RESEARCH
- Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro
- (2012) Mohsin Shah et al. BLOOD CELLS MOLECULES AND DISEASES
- An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
- (2012) Tanja A. Gruber et al. CANCER CELL
- Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
- (2012) Mike Dennis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
- (2012) Qiang Wen et al. CELL
- The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
- (2012) Jayasree S. Nair et al. CELL CYCLE
- Conditional Aurora A deficiency differentially affects early mouse embryo patterning
- (2012) Yeonsoo Yoon et al. DEVELOPMENTAL BIOLOGY
- Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism
- (2012) Kevin R. Kelly et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models
- (2012) Clarisse Thiollier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
- (2012) S A Hartsink-Segers et al. LEUKEMIA
- Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells
- (2012) Aarthi Jayanthan et al. LEUKEMIA & LYMPHOMA
- Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
- (2012) Fei Fei et al. Molecular Cancer
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model
- (2011) Hongfeng Yuan et al. CARCINOGENESIS
- The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
- (2011) Deborah R. Wysong et al. CELL CYCLE
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Genetic disruption of aurora B uncovers an essential role for aurora C during early mammalian development
- (2011) G. Fernandez-Miranda et al. DEVELOPMENT
- Normal and malignant megakaryopoiesis
- (2011) Qiang Wen et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia-a study of 531 Southeast Asian children by the Ma-Spore study group
- (2011) Shuangjie Leow et al. HEMATOLOGICAL ONCOLOGY
- AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas
- (2011) Wenqing Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora A and Aurora B jointly coordinate chromosome segregation and anaphase microtubule dynamics
- (2011) Nadia Hégarat et al. JOURNAL OF CELL BIOLOGY
- Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells
- (2011) Jen-Hui Tsou et al. JOURNAL OF PATHOLOGY
- A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia
- (2011) Kosuke Tsuboi et al. LEUKEMIA RESEARCH
- Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation
- (2011) Jabbar Khan et al. PLoS One
- Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process
- (2010) L. Lordier et al. BLOOD
- The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
- (2010) Kevin R. Kelly et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
- (2009) A. Oke et al. CANCER RESEARCH
- Deregulated Aurora-B induced tetraploidy promotes tumorigenesis
- (2009) Hao G. Nguyen et al. FASEB JOURNAL
- Molecular Distinctions between Aurora A and B: A Single Residue Change Transforms Aurora A into Correctly Localized and Functional Aurora B
- (2009) Fabienne Hans et al. MOLECULAR BIOLOGY OF THE CELL
- Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
- (2009) P. Kaestner et al. MOLECULAR CANCER THERAPEUTICS
- A single amino acid change converts Aurora-A into Aurora-B-like kinase in terms of partner specificity and cellular function
- (2009) J. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating mutations in human acute megakaryoblastic leukemia
- (2008) S. Malinge et al. BLOOD
- Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
- (2008) L. Lordier et al. BLOOD
- Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
- (2008) E. Walsby et al. HAEMATOLOGICA
- Aurora A Is Essential for Early Embryonic Development and Tumor Suppression
- (2008) Lin-Yu Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development
- (2008) D. O. Cowley et al. MOLECULAR AND CELLULAR BIOLOGY
- Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
- (2008) Libor Macůrek et al. NATURE
- Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
- (2008) A. Seki et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now